688076 诺泰生物
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产1,222,2152.19%1,196,073807,126664,592603,856
在建工程219,64718.12%185,960180,11034,8549,879
无形资产110,064-1.82%112,10098,18588,57587,110
商誉156,3360.00%156,336156,336160,920162,199
其他非流动资产462,75415.11%402,010228,07273,86444,621
2,171,0175.78%2,052,4791,469,8301,022,805907,665

流动资产
货币资金544,180-27.35%749,082399,965591,87669,712
应收账款333,75212.68%296,195245,465139,375107,422
存货394,4934.59%377,174323,484250,816184,995
其他流动资产275,819281.41%72,31583,556122,034125,778
1,548,2443.58%1,494,7671,052,4701,104,101487,908

流动负债
短期借款681,65124.84%546,019318,72577,275177,947
应付票据89,934-20.84%113,61658,20551,2091,457
应付帐款152,378-18.50%186,959110,73676,920105,443
其他流动负债139,63510.17%126,74263,65769,99297,363
1,063,5989.27%973,335551,323275,395382,210
流动资产净值484,646-7.05%521,432501,146828,705105,698
资产总额减流动负债2,655,6633.18%2,573,9111,970,9761,851,5101,013,363

非流动负债
长期借款0--00032,107
应付债券292,4492.08%286,492000
其他非流动负债94,859-3.32%98,11546,08942,74215,231
387,3080.70%384,60746,08942,74247,338

总权益
    实收股本213,1840.00%213,184213,184213,184159,888
    储备项目2,036,8784.08%1,957,0851,697,0421,598,199803,456
股东权益2,250,0623.68%2,170,2681,910,2261,811,383963,344
非控股权益18,292-3.90%19,03514,661(2,614)2,681